Paul W. Sandman
Geen lopende functies
Profiel
Paul W.
Sandman served as an Independent Director at PDL BioPharma, Inc. from 2008 to 2020.
Prior to that, he was the Secretary, Executive VP & General Counsel at Boston Scientific Corp.
from 1993 to 2008 and the Secretary, Senior Vice President & General Counsel at Wang Laboratories, Inc. from 1981 to 1993.
Sandman received his undergraduate degree from Boston College and his graduate degree from Harvard Law School.
Eerdere bekende functies van Paul W. Sandman
| Bedrijven | Functie | Einde |
|---|---|---|
| PDL BIOPHARMA, INC. | Director/Board Member | 15-01-2020 |
| BOSTON SCIENTIFIC CORPORATION | General Counsel | 29-02-2008 |
Wang Laboratories, Inc.
 Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | General Counsel | 01-04-1993 |
Opleiding van Paul W. Sandman
| Boston College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Wang Laboratories, Inc.
Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | Technology Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
